Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) |  Cites / Doc. (2years) |
Ref. / Doc. (2020) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Drug Discovery | journal | 9.921 Q1 | 391 | 246 | 676 | 7779 | 8579 | 315 | 12.40 | 31.62 |  |
| 2 | Journal for ImmunoTherapy of Cancer | journal | 5.060 Q1 | 117 | 508 | 582 | 19284 | 7039 | 571 | 11.60 | 37.96 | |
| 3 | Trends in Pharmacological Sciences | journal | 3.878 Q1 | 244 | 101 | 288 | 6920 | 3228 | 276 | 10.11 | 68.51 | |
| 4 | Drug Discovery Today | journal | 1.778 Q1 | 215 | 249 | 666 | 18949 | 5285 | 629 | 7.37 | 76.10 | |
| 5 | Expert Opinion on Therapeutic Patents | journal | 1.121 Q1 | 88 | 71 | 253 | 6591 | 1462 | 244 | 6.40 | 92.83 | |
| 6 | npj Vaccines | journal | 2.691 Q1 | 47 | 105 | 134 | 5348 | 869 | 133 | 6.16 | 50.93 | |
| 7 | Chinese Medicine | journal | 0.972 Q2 | 56 | 127 | 152 | 7789 | 811 | 150 | 5.94 | 61.33 | |
| 8 | Drugs in Context | journal | 1.262 Q1 | 36 | 69 | 109 | 3474 | 591 | 109 | 5.91 | 50.35 | |
| 9 | Therapeutic Advances in Neurological Disorders | journal | 1.684 Q1 | 68 | 70 | 188 | 3450 | 1063 | 174 | 5.77 | 49.29 | |
| 10 | Neuropsychopharmacology | journal | 2.704 Q1 | 249 | 285 | 891 | 16878 | 5532 | 810 | 5.73 | 59.22 | |
| 11 | Phytotherapy Research | journal | 1.019 Q2 | 158 | 264 | 723 | 18424 | 3888 | 712 | 5.59 | 69.79 | |
| 12 | Advanced Therapeutics | journal | 0.125 Q4 | 39 | 78 | 155 | 8196 | 862 | 152 | 5.56 | 105.08 | |
| 13 | Expert Opinion on Therapeutic Targets | journal | 1.964 Q1 | 106 | 103 | 291 | 12152 | 1629 | 257 | 5.41 | 117.98 | |
| 14 | Acta Pharmacologica Sinica | journal | 1.514 Q1 | 117 | 169 | 498 | 9324 | 2902 | 491 | 5.20 | 55.17 | |
| 15 | Antiviral Chemistry and Chemotherapy | journal | 0.919 Q2 | 59 | 14 | 34 | 711 | 140 | 31 | 5.13 | 50.79 | |
| 16 | Expert Opinion on Investigational Drugs | journal | 1.410 Q1 | 117 | 132 | 336 | 11059 | 1672 | 321 | 5.10 | 83.78 | |
| 17 | Clinical Pharmacokinetics | journal | 1.549 Q1 | 184 | 120 | 362 | 6452 | 1898 | 333 | 5.09 | 53.77 | |
| 18 | BioDrugs | journal | 1.919 Q1 | 79 | 62 | 166 | 4406 | 981 | 155 | 4.90 | 71.06 | |
| 19 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.916 Q2 | 92 | 185 | 471 | 9500 | 2428 | 471 | 4.82 | 51.35 | |
| 20 | Neuropharmacology | journal | 1.760 Q1 | 191 | 417 | 1332 | 35128 | 6810 | 1306 | 4.79 | 84.24 | |
| 21 | Journal of Antimicrobial Chemotherapy | journal | 2.124 Q1 | 221 | 525 | 1711 | 15296 | 8485 | 1490 | 4.78 | 29.14 | |
| 22 | International Journal of Neuropsychopharmacology | journal | 1.897 Q1 | 125 | 51 | 308 | 3211 | 1584 | 299 | 4.77 | 62.96 | |
| 23 | Expert Review of Vaccines | journal | 1.864 Q1 | 105 | 94 | 314 | 8262 | 1569 | 289 | 4.67 | 87.89 | |
| 24 | Drug Safety | journal | 1.377 Q1 | 140 | 126 | 372 | 5175 | 1432 | 313 | 4.14 | 41.07 | |
| 25 | CNS Neuroscience and Therapeutics | journal | 1.403 Q1 | 91 | 128 | 376 | 5889 | 1658 | 331 | 4.08 | 46.01 | |
| 26 | Expert Opinion on Drug Metabolism and Toxicology | journal | 1.031 Q2 | 100 | 95 | 323 | 10735 | 1351 | 299 | 4.04 | 113.00 | |
| 27 | Expert Opinion on Biological Therapy | journal | 1.088 Q1 | 102 | 149 | 427 | 11491 | 1648 | 395 | 3.80 | 77.12 | |
| 28 | PharmacoEconomics | journal | 1.809 Q1 | 118 | 112 | 359 | 4864 | 1371 | 314 | 3.77 | 43.43 | |
| 29 | Molecular Diagnosis and Therapy | journal | 1.322 Q1 | 68 | 61 | 190 | 3981 | 733 | 183 | 3.74 | 65.26 | |
| 30 | Expert Opinion on Emerging Drugs | journal | 0.975 Q2 | 54 | 41 | 78 | 4420 | 273 | 76 | 3.70 | 107.80 | |
| 31 | Journal of Psychopharmacology | journal | 1.333 Q1 | 135 | 143 | 444 | 8729 | 1717 | 428 | 3.69 | 61.04 | |
| 32 | Pharmaceutical Biology | journal | 0.702 Q2 | 88 | 147 | 469 | 5985 | 1782 | 468 | 3.48 | 40.71 | |
| 33 | Journal of Pharmacy and Pharmacology | journal | 0.745 Q2 | 137 | 169 | 501 | 8431 | 1702 | 495 | 3.43 | 49.89 | |
| 34 | RSC Medicinal Chemistry | journal | 0.754 Q2 | 74 | 104 | 622 | 6317 | 2143 | 615 | 3.39 | 60.74 | |
| 35 | British Journal of Clinical Pharmacology | journal | 1.216 Q1 | 167 | 259 | 933 | 10206 | 3326 | 783 | 3.29 | 39.41 | |
| 36 | ChemMedChem | journal | 0.817 Q2 | 119 | 253 | 689 | 13096 | 2238 | 681 | 3.23 | 51.76 | |
| 37 | Pharmacogenomics Journal | journal | 0.804 Q2 | 95 | 88 | 232 | 4015 | 740 | 226 | 3.15 | 45.63 | |
| 38 | Expert Opinion on Pharmacotherapy | journal | 0.873 Q2 | 93 | 230 | 647 | 16897 | 1968 | 568 | 3.01 | 73.47 | |
| 39 | Future Medicinal Chemistry | journal | 0.708 Q2 | 90 | 160 | 591 | 9033 | 1832 | 541 | 2.86 | 56.46 | |
| 40 | DARU, Journal of Pharmaceutical Sciences | journal | 0.645 Q2 | 58 | 70 | 121 | 3671 | 368 | 118 | 2.69 | 52.44 | |
| 41 | Chemical Biology and Drug Design | journal | 0.590 Q3 | 91 | 121 | 598 | 5669 | 1576 | 536 | 2.62 | 46.85 | |
| 42 | Cardiovascular Therapeutics | journal | 0.818 Q2 | 54 | 61 | 160 | 3026 | 423 | 158 | 2.58 | 49.61 | |
| 43 | Journal of Food Biochemistry | journal | 0.507 Q3 | 64 | 389 | 753 | 19002 | 1897 | 747 | 2.57 | 48.85 | |
| 44 | BMC pharmacology & toxicology | journal | 0.618 Q3 | 43 | 88 | 255 | 3326 | 674 | 255 | 2.54 | 37.80 | |
| 45 | Drugs in R and D | journal | 0.873 Q2 | 54 | 37 | 131 | 1464 | 397 | 127 | 2.48 | 39.57 | |
| 46 | Immunopharmacology and Immunotoxicology | journal | 0.701 Q2 | 61 | 70 | 188 | 3465 | 492 | 184 | 2.39 | 49.50 | |
| 47 | Clinical and Experimental Pharmacology and Physiology | journal | 0.752 Q2 | 115 | 209 | 455 | 9361 | 1196 | 421 | 2.37 | 44.79 | |
| 48 | Journal of Antibiotics | journal | 0.560 Q3 | 92 | 121 | 466 | 4022 | 1297 | 436 | 2.36 | 33.24 | |
| 49 | Fundamental and Clinical Pharmacology | journal | 0.655 Q2 | 85 | 79 | 222 | 3170 | 570 | 205 | 2.23 | 40.13 | |
| 50 | Antiviral Therapy | journal | 0.747 Q2 | 93 | 20 | 252 | 762 | 512 | 243 | 2.22 | 38.10 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data